FR2081561A1 - - Google Patents

Info

Publication number
FR2081561A1
FR2081561A1 FR7007551A FR7007551A FR2081561A1 FR 2081561 A1 FR2081561 A1 FR 2081561A1 FR 7007551 A FR7007551 A FR 7007551A FR 7007551 A FR7007551 A FR 7007551A FR 2081561 A1 FR2081561 A1 FR 2081561A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7007551A
Other languages
French (fr)
Other versions
FR2081561B1 (nl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR707007551A priority Critical patent/FR2081561B1/fr
Priority to IL36214A priority patent/IL36214A/xx
Priority to ZA711131A priority patent/ZA711131B/xx
Priority to JP1043271A priority patent/JPS5343497B1/ja
Priority to DK95871AA priority patent/DK124127B/da
Priority to AT177571A priority patent/AT307636B/de
Priority to DE2109853A priority patent/DE2109853B2/de
Priority to CH302971A priority patent/CH536829A/fr
Priority to ES388783A priority patent/ES388783A1/es
Priority to CA106701A priority patent/CA934367A/en
Priority to BE763660A priority patent/BE763660A/xx
Priority to NLAANVRAGE7102735,A priority patent/NL169592C/nl
Priority to SE02671/71A priority patent/SE368397B/xx
Priority to GB2297071A priority patent/GB1323383A/en
Publication of FR2081561A1 publication Critical patent/FR2081561A1/fr
Application granted granted Critical
Publication of FR2081561B1 publication Critical patent/FR2081561B1/fr
Priority to US517380A priority patent/US3919267A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR707007551A 1970-03-03 1970-03-03 Expired FR2081561B1 (nl)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR707007551A FR2081561B1 (nl) 1970-03-03 1970-03-03
IL36214A IL36214A (en) 1970-03-03 1971-02-17 13beta-ethyl-17alpha-methyl-18,19-dinorpregna-4,9-diene-3,20-dione,process of preparation and pharmaceutical compositions containing it
ZA711131A ZA711131B (en) 1970-03-03 1971-02-22 New dienic steroid derivative and process of preparation
BE763660A BE763660A (fr) 1970-03-03 1971-03-02 Nouveau derive steroide dienique et procede de preparation
AT177571A AT307636B (de) 1970-03-03 1971-03-02 Verfahren zur Herstellung des neuen 3,20-Dioxo-13β-äthyl-17α-methyl-18,19-dinorpregna-4,9-diens
DE2109853A DE2109853B2 (de) 1970-03-03 1971-03-02 33-Dioxo-13 ß -äthyl-17 a -meth pregna- 4,9-dien, Verfahren zu dessen Herstellung sowie dieses enthaltende pharmazeutische Zusammensetzungen
CH302971A CH536829A (fr) 1970-03-03 1971-03-02 Procédé de préparation d'un dérivé stéroïde diénique
ES388783A ES388783A1 (es) 1970-03-03 1971-03-02 Procedimiento de preparacion de 3,20 - dioxo - 13 beta - etil - 17 alfa - metil - 18,19 - dinor - pregna - 4,9 - die-no.
JP1043271A JPS5343497B1 (nl) 1970-03-03 1971-03-02
DK95871AA DK124127B (da) 1970-03-03 1971-03-02 Analogifremgangsmåde til fremstilling af 3,20-dioxo-13β-ethyl-17α-methyl-18,19-di-nor-pregna-4,9-dien.
NLAANVRAGE7102735,A NL169592C (nl) 1970-03-03 1971-03-02 Werkwijze voor het bereiden of vervaardigen van een geneesmiddel en werkwijze voor het bereiden van een geneeskrachtige verbinding, geschikt voor gebruik bij de bereiding van dit geneesmiddel.
SE02671/71A SE368397B (nl) 1970-03-03 1971-03-02
CA106701A CA934367A (en) 1970-03-03 1971-03-02 Procede de preparation d'un nouveau derive steroide dienique
GB2297071A GB1323383A (en) 1970-03-03 1971-04-19 Pregna-4,9-diene processes for its preparation and compositions thereof
US517380A US3919267A (en) 1970-03-03 1974-10-23 13{62 -ethyl-17{60 -methyl-18,19-dinor-{66 {hu 4,9{b -pregnadiene-3,20-dione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR707007551A FR2081561B1 (nl) 1970-03-03 1970-03-03

Publications (2)

Publication Number Publication Date
FR2081561A1 true FR2081561A1 (nl) 1971-12-10
FR2081561B1 FR2081561B1 (nl) 1973-04-06

Family

ID=9051572

Family Applications (1)

Application Number Title Priority Date Filing Date
FR707007551A Expired FR2081561B1 (nl) 1970-03-03 1970-03-03

Country Status (14)

Country Link
JP (1) JPS5343497B1 (nl)
AT (1) AT307636B (nl)
BE (1) BE763660A (nl)
CA (1) CA934367A (nl)
CH (1) CH536829A (nl)
DE (1) DE2109853B2 (nl)
DK (1) DK124127B (nl)
ES (1) ES388783A1 (nl)
FR (1) FR2081561B1 (nl)
GB (1) GB1323383A (nl)
IL (1) IL36214A (nl)
NL (1) NL169592C (nl)
SE (1) SE368397B (nl)
ZA (1) ZA711131B (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173408B (it) * 1984-02-29 1987-06-24 Hudson Italiana Spa Ventilatore,del tipo a pale cave,avente l'interno di ciascuna pala sotto vuoto
DE102007027636A1 (de) * 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1487510A (fr) * 1965-06-01 1967-07-07 Merck & Co Inc Procédé de fabrication de gonénols et gonadiénols substitués

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1487510A (fr) * 1965-06-01 1967-07-07 Merck & Co Inc Procédé de fabrication de gonénols et gonadiénols substitués

Also Published As

Publication number Publication date
NL169592C (nl) 1982-08-02
ZA711131B (en) 1972-03-29
CA934367A (en) 1973-09-25
DE2109853B2 (de) 1979-06-21
JPS5343497B1 (nl) 1978-11-20
GB1323383A (en) 1973-07-11
IL36214A (en) 1974-09-10
SE368397B (nl) 1974-07-01
IL36214A0 (en) 1971-04-28
DE2109853A1 (de) 1971-09-23
DE2109853C3 (nl) 1980-02-21
CH536829A (fr) 1973-05-15
FR2081561B1 (nl) 1973-04-06
DK124127B (da) 1972-09-18
BE763660A (fr) 1971-09-02
NL7102735A (nl) 1971-09-07
ES388783A1 (es) 1974-02-16
AT307636B (de) 1973-05-25

Similar Documents

Publication Publication Date Title
AR204384A1 (nl)
ATA96471A (nl)
FR2081561B1 (nl)
AU2044470A (nl)
AU2085370A (nl)
AU2017870A (nl)
AU2130570A (nl)
AR195465A1 (nl)
AU2115870A (nl)
AU1083170A (nl)
AU1872870A (nl)
AU1879170A (nl)
AU1881070A (nl)
AU1918570A (nl)
AU1943370A (nl)
AU1969370A (nl)
AU1832970A (nl)
AU2144270A (nl)
AU2061170A (nl)
AU2112570A (nl)
AU2119370A (nl)
AU1086670A (nl)
AU2130770A (nl)
ATA672271A (nl)
AU1974970A (nl)

Legal Events

Date Code Title Description
ST Notification of lapse